Grace Therapeutics Inc (GRCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 08-2015 | 06-2015 | 05-2015 | 03-2015 | 02-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,030 | 980 | 980 | 1,160 | N/A |
| Marketable Securities | 10,310 | 12,920 | 12,920 | 15,200 | N/A |
| Receivables | 310 | 380 | 380 | 760 | N/A |
| Inventories | 50 | 60 | 60 | 70 | N/A |
| Other current assets | 150 | 190 | 190 | 300 | 0 |
| TOTAL | $12,850 | $14,530 | $14,530 | $17,490 | $N/A |
| Non-Current Assets | |||||
| Other Non-Current Assets | 12,850 | 13,690 | 13,690 | 15,580 | 0 |
| TOTAL | $12,850 | $13,690 | $13,690 | $15,580 | $N/A |
| Total Assets | $25,870 | $28,400 | $28,400 | $33,140 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 840 | 960 | 960 | 960 | 0 |
| Other current liabilities | 100 | 780 | 780 | 480 | N/A |
| TOTAL | $950 | $1,750 | $1,750 | $1,440 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 480 | 520 | 520 | 2,090 | 0 |
| TOTAL | $480 | $520 | $520 | $2,090 | $N/A |
| Total Liabilities | $1,440 | $2,270 | $2,270 | $3,540 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | N/A | N/A | 222 |
| Common Shares | 48,470 | 49,780 | 49,780 | 54,890 | N/A |
| Retained earnings | -27,820 | -27,680 | -27,680 | -29,670 | N/A |
| TOTAL | $24,430 | $26,120 | $26,120 | $29,590 | $N/A |
| Total Liabilities And Equity | $25,870 | $28,390 | $28,390 | $33,130 | $0 |